Age-dependent regulation of depression-like behaviors through modulation of adrenergic receptor α1A subtype expression revealed by the analysis of interleukin-1 receptor antagonist knockout mice

Neuroscience

Volumn 192, Issue , 2011, Pages 475-484

  Wakabayashi, C ^a,b   Kiyama, Y ^a   Kunugi, H ^b,c   Manabe, T ^a,c   Iwakura, Y ^a,c  

^a UNIVERSITY OF TOKYO   (Japan)

^b NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Adrenergic receptor; Behavior; Cerebral cortex; Depression; IL 1 receptor antagonist (IL 1Ra); Knockout mouse

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; 5 HYDROXYINDOLEACETIC ACID; ALPHA 1A ADRENERGIC RECEPTOR; DOPAMINE; HOMOVANILLIC ACID; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; MESSENGER RNA; NORADRENALIN; PRAZOSIN; PROPRANOLOL; SEROTONIN; TRYPTOPHAN; YOHIMBINE;

AGE; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN LEVEL; BRAIN TISSUE; CONDITIONING; CONTROLLED STUDY; DEPRESSION; EXPERIMENTAL TEST; FEAR; FORCED SWIMMING TEST; GENE EXPRESSION; GENETIC MANIPULATION; HIPPOCAMPUS; IMMOBILIZATION STRESS; KNOCKOUT MOUSE; MALE; MONOAMINE METABOLISM; MOUSE; MOUSE MUTANT; NONHUMAN; OPEN FIELD TEST; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; ROTAROD TEST; SIGNAL TRANSDUCTION; TAIL SUSPENSION TEST; WILD TYPE;

ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DEPRESSION; DISEASE MODELS, ANIMAL; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, ADRENERGIC, ALPHA-1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 80052267321     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2011.06.031     Document Type: Article

References (50)

1. Ambrosini P.J. A review of pharmacotherapy of major depression in children and adolescents. Psychiatr Serv 2000, 51:627-633.
2. Besedovsky H., del Rey A., Sorkin E., Dinarello C.A. Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. Science 1986, 233:652-654.
3. Binfaré R.W., Rosa A.O., Lobato K.R., Santos A.R., Rodrigues A.L. Ascorbic acid administration produces an antidepressant-like effect: evidence for the involvement of monoaminergic neurotransmission. Prog Neuropsychopharmacol Biol Psychiatry 2009, 33:530-540.
4. Blanco C., Antia S.X., Liebowitz M.R. Pharmacotherapy of social anxiety disorder. Biol Psychiatry 2002, 51:109-120.
5. Brocardo P.S., Budni J., Kaster M.P., Santos A.R., Rodrigues A.L. Folic acid administration produces an antidepressant-like effect in mice: evidence for the involvement of the serotonergic and noradrenergic systems. Neuropharmacology 2008, 54:464-473.
6. Chalothorn D., McCune D.F., Edelmann S.E., García-Cazarín M.L., Tsujimoto G., Piascik M.T. Differences in the cellular localization and agonist-mediated internalization properties of the α1-adrenoceptor subtypes. Mol Pharmacol 2002, 61:1008-1016.
7. Chida D., Hashimoto O., Kuwahara M., Sagara H., Osaka T., Tsubone H., Iwakura Y. Increased fat: carbohydrate oxidation ratio in Il1ra (-/-) mice on a high-fat diet is associated with increased sympathetic tone. Diabetologia 2008, 51:1698-1706.
8. Cragnolini A.B., Schiöth H.B., Scimonelli T.N. Anxiety-like behavior induced by IL-1β is modulated by alpha-MSH through central melanocortin-4 receptors. Peptides 2006, 27:1451-1456.
9. Detke M.J., Rickels M., Lucki I. Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology (Berl) 1995, 121:66-72.
10. Deupree J.D., Reed A.L., Bylund D.B. Differential effects of the tricyclic antidepressant desipramine on the density of adrenergic receptors in juvenile and adult rats. J Pharmacol Exp Ther 2007, 321:770-776.
11. Dias Elpo Zomkowski A., Oscar Rosa A., Lin J., Santos A.R., Calixto J.B., Lucia Severo Rodrigues A. Evidence for serotonin receptor subtypes involvement in agmatine antidepressant like-effect in the mouse forced swimming test. Brain Res 2004, 1023:253-263.
12. Dinarello C.A. Interleukin-1 and interleukin-1 antagonism. Blood 1991, 77:1627-1652.
13. Doze V.A., Handel E.M., Jensen K.A., Darsie B., Luger E.J., Haselton J.R., Talbot J.N., Rorabaugh B.R. α1A-and α1B-adrenergic receptors differentially modulate antidepressant-like behavior in the mouse. Brain Res 2009, 1285:148-157.
14. Dunn A.J. Endotoxin-induced activation of cerebral catecholamine and serotonin metabolism: comparison with interleukin-1. J Pharmacol Exp Ther 1992, 261:964-969.
15. Dunn A.J. Cytokine activation of the HPA axis. Ann N Y Acad Sci 2000, 917:608-617.
16. Dunn A.J., Swiergiel A.H. Effects of interleukin-1 and endotoxin in the forced swim and tail suspension tests in mice. Pharmacol Biochem Behav 2005, 81:688-693.
17. Horai R., Asano M., Sudo K., Kanuka H., Suzuki M., Nishihara M., Takahashi M., Iwakura Y. Production of mice deficient in genes for interleukin (IL)-1α, IL-1β, IL-1α/β, and IL-1 receptor antagonist shows that IL-1b is crucial in turpentine-induced fever development and glucocorticoid secretion. J Exp Med 1998, 187:1463-1475.
18. Invernizzi R.W., Garattini S. Role of presynaptic α2-adrenoceptors in antidepressant action: recent findings from microdialysis studies. Prog Neuropsychopharmacol Biol Psychiatry 2004, 28:819-827.
19. Kabiersch A., del Rey A., Honegger C.G., Besedovsky H.O. Interleukin-1 induces changes in norepinephrine metabolism in the rat brain. Brain Behav Immun 1988, 2:267-274.
20. Kiyama Y., Manabe T., Sakimura K., Kawakami F., Mori H., Mishina M. Increased thresholds for long-term potentiation and contextual learning in mice lacking the NMDA-type glutamate receptor ε1 subunit. J Neurosci 1998, 18:6704-6712.
21. Lacosta S., Merali Z., Anisman H. Influence of interleukin-1beta on exploratory behaviors, plasma ACTH, corticosterone, and central biogenic amines in mice. Psychopharmacology (Berl) 1998, 137:351-361.
22. Lanni C., Govoni S., Lucchelli A., Boselli C. Depression and antidepressants: molecular and cellular aspects. Cell Mol Life Sci 2009, 66:2985-3008.
23. Matsuki T., Horai R., Sudo K., Iwakura Y. IL-1 plays an important role in lipid metabolism by regulating insulin levels under physiological conditions. J Exp Med 2003, 198:877-888.
24. McNamee E.N., Griffin E.W., Ryan K.M., Ryan K.J., Heffernan S., Harkin A., Connor T.J. Noradrenaline acting at beta-adrenoceptors induces expression of IL-1β and its negative regulators IL-1ra and IL-1RII, and drives an overall anti-inflammatory phenotype in rat cortex. Neuropharmacology 2010, 59:37-48.
25. Menkes D.B., Kehne J.H., Gallager D.W., Aghajanian G.K., Davis M. Functional supersensitivity of CNS α1-adrenoceptors following chronic antidepressant treatment. Life Sci 1983, 33:181-188.
26. Minami M., Kuraishi Y., Yamaguchi T., Nakai S., Hirai Y., Satoh M. Immobilization stress induces interleukin-1β mRNA in the rat hypothalamus. Neurosci Lett 1991, 123:254-256.
27. MohanKumar P.S., Quadri S.K. Systemic administration of interleukin-1 stimulates norepinephrine release in the paraventricular nucleus. Life Sci 1993, 52:1961-1967.
28. Morris D.P., Lei B., Wu Y.X., Michelotti G.A., Schwinn D.A. The α1a-adrenergic receptor occupies membrane rafts with its G protein effectors but internalizes via clathrin-coated pits. J Biol Chem 2008, 283:2973-2985.
29. Murrin L.C., Sanders J.D., Bylund D.B. Comparison of the maturation of the adrenergic and serotonergic neurotransmitter systems in the brain: implications for differential drug effects on juveniles and adults. Biochem Pharmacol 2007, 73:1225-1236.
30. Nalepa I., Kreiner G., Kowalska M., Sanak M., Zelek-Molik A., Vetulani J. Repeated imipramine and electroconvulsive shock increase α1A-adrenoceptor mRNA level in rat prefrontal cortex. Eur J Pharmacol 2002, 444:151-159.
31. Nguyen K.T., Deak T., Owens S.M., Kohno T., Fleshner M., Watkins LR, Maier S.F. Exposure to acute stress induces brain interleukin-1β protein in the rat. J Neurosci 1998, 18:2239-2246.
32. Petit-Demouliere B., Chenu F., Bourin M. Forced swimming test in mice: a review of antidepressant activity. Psychopharmacology (Berl) 2005, 177:245-255.
33. Porsolt R.D., Bertin A., Jalfre M. Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 1977, 229:327-336.
34. Price R.R., Morris D.P., Biswas G., Smith M.P., Schwinn D.A. Acute agonist-mediated desensitization of the human α1a-adrenergic receptor is primarily independent of carboxyl terminus regulation: implications for regulation of α1aAR splice variants. J Biol Chem 2002, 277:9570-9579.
35. Rehavi M., Ramot O., Yavetz B., Sokolovsky M. Amitriptyline: long-term treatment elevates α-adrenergic and muscarinic receptor binding in mouse brain. Brain Res 1980, 194:443-453.
36. Savegnago L., Jesse C.R., Pinto L.G., Rocha J.B., Nogueira C.W., Zeni G. Monoaminergic agents modulate antidepressant-like effect caused by diphenyl diselenide in rats. Prog Neuropsychopharmacol Biol Psychiatry 2007, 31:1261-1269.
37. Shintani F., Kanba S., Nakaki T., Nibuya M., Kinoshita N., Suzuki E., Yagi G., Kato R., Asai M. Interleukin-1β augments release of norepinephrine, dopamine, and serotonin in the rat anterior hypothalamus. J Neurosci 1993, 13:3574-3581.
38. Shintani F., Nakaki T., Kanba S., Sato K., Yagi G., Shiozawa M., Aiso S., Kato R., Asai M. Involvement of interleukin-1 in immobilization stress-induced increase in plasma adrenocorticotropic hormone and in release of hypothalamic monoamines in the rat. J Neurosci 1995, 15:1961-1970.
39. Steru L., Chermat R., Thierry B., Simon P. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology (Berl) 1985, 85:367-370.
40. Stone E.A., Quartermain D. Alpha-1-noradrenergic neurotransmission, corticosterone, and behavioral depression. Biol Psychiatry 1999, 46:1287-1300.
41. Stone E.A., Quartermain D., Lin Y., Lehmann M.L. Central α1-adrenergic system in behavioral activity and depression. Biochem Pharmacol 2007, 73:1063-1075.
42. Subhash M.N., Nagaraja M.R., Sharada S., Vinod K.Y. Cortical alpha-adrenoceptor downregulation by tricyclic antidepressants in the rat brain. Neurochem Int 2003, 43:603-609.
43. Suzuki E., Shintani F., Kanba S., Asai M., Nakaki T. Immobilization stress increases mRNA levels of interleukin-1 receptor antagonist in various rat brain regions. Cell Mol Neurobiol 1997, 17:557-562.
44. Swiergiel A.H., Dunn A.J. Effects of interleukin-1β and lipopolysaccharide on behavior of mice in the elevated plus-maze and open field tests. Pharmacol Biochem Behav 2007, 86:651-659.
45. Turnbull A.V., Rivier C.L. Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: actions and mechanisms of action. Physiol Rev 1999, 79:1-71.
46. Vázquez-Prado J., Medina L.C., Romero-Avila M.T., González-Espinosa C., García-Sáinz J.A. Norepinephrine- and phorbol ester-induced phosphorylation of α1a-adrenergic receptors: functional aspects. J Biol Chem 2000, 275:6553-6559.
47. Weller E.B., Weller R.A. Treatment options in the management of adolescent depression. J Affect Disord 2000, 61:S23-S28.
48. Willner P. Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology 2005, 52:90-110.
49. Zalcman S., Green-Johnson J.M., Murray L., Nance D.M., Dyck D., Anisman H., Greenberg A.H. Cytokine-specific central monoamine alterations induced by interleukin-1, -2 and -6. Brain Res 1994, 643:40-49.
50. Zhu C.B., Lindler K.M., Owens A.W., Daws L.C., Blakely R.D., Hewlett W.A. Interleukin-1 receptor activation by systemic lipopolysaccharide induces behavioral despair linked to MAPK regulation of CNS serotonin transporters. Neuropsychopharmacology 2010, 35:2510-2520.